organization · Reporting owner
MOUNT SINAI HEALTH SYSTEM, INC.
Disclosed activity across 2 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Renalytix plcRNLX · Entity 7446 | 10% owner | November 01, 2024 | November 05, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Renalytix plc
Report date November 01, 2024 · Filed November 05, 2024
Jointly reported with ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, MOUNT SINAI HOSPITAL, MOUNT SINAI HOSPITALS GROUP, INC.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 32,683,998 |
Reported balance
After 2024-11-01 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2024-11-01 · Other · Acquired 13,366,750 · Balance 32,683,998 F1: On November 1, 2024, Icahn School of Medicine at Mount Sinai ("ISMMS") acquired 13,366,750 Ordinary Shares of the Issuer in a private placement of the Issuer (the "Private Placement") pursuant to the Subscription Letter dated as of September 30, 2024, after the Issuer's receipt of the requisite shareholder approval. In connection with the Private Placement, the Issuer, in two tranches, issued (a) an aggregate of 92,773,922 Ordinary Shares pursuant to a Placing Agreement with Oberon Investments Limited, (b) an aggregate of 38,387,634 Ordinary Shares (including the Ordinary Shares issued to ISMMS) to certain investors pursuant to Subscription Letters, and (c) an aggregate of 36,550,543 Ordinary Shares as a result of the restructuring of certain convertible bonds. F2: ISMMS acquired the Ordinary Shares for approximately $1.55 million, which is equivalent to a price of 9 pence per Ordinary Share (or approximately $0.116 per share based on a conversion rate of 1 GBP to $1.2920 on November 1, 2024). F3: The securities reported herein are held directly by ISMMS. F4: As the sole member of The Mount Sinai Hospital ("MSH"), Mount Sinai Hospitals Group, Inc. ("MSHG") may be deemed to beneficially own the securities held by MSH. As the sole member of MSHG, Mount Sinai Health System, Inc. ("MSHS") may be deemed to beneficially own the securities beneficially owned by MSHG. As the sole member of ISMMS, MSHS may be deemed to beneficially own the securities held by ISMMS. Each of the reporting persons disclaims beneficial ownership of all such securities reported herein, except to the extent of its pecuniary interest, if any. |
| American Depositary SharesSEC Table I · non-derivative | Direct | 2,331,239 |
Reported balance
Holding disclosure · report date 2024-11-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,331,239 F5: Each American Depositary Share of the Issuer represents two Ordinary Shares of the Issuer. F4: As the sole member of The Mount Sinai Hospital ("MSH"), Mount Sinai Hospitals Group, Inc. ("MSHG") may be deemed to beneficially own the securities held by MSH. As the sole member of MSHG, Mount Sinai Health System, Inc. ("MSHS") may be deemed to beneficially own the securities beneficially owned by MSHG. As the sole member of ISMMS, MSHS may be deemed to beneficially own the securities held by ISMMS. Each of the reporting persons disclaims beneficial ownership of all such securities reported herein, except to the extent of its pecuniary interest, if any. F6: 948,750 American Depositary Shares are held directly by MSH and 1,382,489 American Depositary Shares are held directly by ISMMS. |
Filing footnotes · ownership attribution and instrument terms
F1: On November 1, 2024, Icahn School of Medicine at Mount Sinai ("ISMMS") acquired 13,366,750 Ordinary Shares of the Issuer in a private placement of the Issuer (the "Private Placement") pursuant to the Subscription Letter dated as of September 30, 2024, after the Issuer's receipt of the requisite shareholder approval. In connection with the Private Placement, the Issuer, in two tranches, issued (a) an aggregate of 92,773,922 Ordinary Shares pursuant to a Placing Agreement with Oberon Investments Limited, (b) an aggregate of 38,387,634 Ordinary Shares (including the Ordinary Shares issued to ISMMS) to certain investors pursuant to Subscription Letters, and (c) an aggregate of 36,550,543 Ordinary Shares as a result of the restructuring of certain convertible bonds.
F2: ISMMS acquired the Ordinary Shares for approximately $1.55 million, which is equivalent to a price of 9 pence per Ordinary Share (or approximately $0.116 per share based on a conversion rate of 1 GBP to $1.2920 on November 1, 2024).
F3: The securities reported herein are held directly by ISMMS.
F4: As the sole member of The Mount Sinai Hospital ("MSH"), Mount Sinai Hospitals Group, Inc. ("MSHG") may be deemed to beneficially own the securities held by MSH. As the sole member of MSHG, Mount Sinai Health System, Inc. ("MSHS") may be deemed to beneficially own the securities beneficially owned by MSHG. As the sole member of ISMMS, MSHS may be deemed to beneficially own the securities held by ISMMS. Each of the reporting persons disclaims beneficial ownership of all such securities reported herein, except to the extent of its pecuniary interest, if any.
F5: Each American Depositary Share of the Issuer represents two Ordinary Shares of the Issuer.
F6: 948,750 American Depositary Shares are held directly by MSH and 1,382,489 American Depositary Shares are held directly by ISMMS.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
GeneDx Holdings Corp.
Report date November 15, 2024 · Filed November 19, 2024
Jointly reported with ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Section 16 reporting ended · disclosed 2024-11-19. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 2,719,692 |
Last balance in matching sequence
After 2024-11-18 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2024-11-15 · Sale · Disposed 20,359 · Balance 2,846,474 F1: Reflects securities directly held by Icahn School of Medicine at Mount Sinai. The sole member of Icahn School of Medicine at Mount Sinai is Mount Sinai Health System, Inc. Row 2 · 2024-11-18 · Sale · Disposed 126,782 · Balance 2,719,692 F1: Reflects securities directly held by Icahn School of Medicine at Mount Sinai. The sole member of Icahn School of Medicine at Mount Sinai is Mount Sinai Health System, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects securities directly held by Icahn School of Medicine at Mount Sinai. The sole member of Icahn School of Medicine at Mount Sinai is Mount Sinai Health System, Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 18, 2024 Filed Nov 19, 2024 20:00 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | SaleClass A Common Stock | 126,782 | $70.78 | $8,973,059.44 |
DisclosureSEC source: 0000950170-24-128961 · ownership.xml · nonDerivative · entry 2 ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · CIK 0001883139 · 10% owner MOUNT SINAI HEALTH SYSTEM, INC. · CIK 0001883135 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,719,692 F1 · balance_after: Reflects securities directly held by Icahn School of Medicine at Mount Sinai. The sole member of Icahn School of Medicine at Mount Sinai is Mount Sinai Health System, Inc. Read SEC document |
| November 15, 2024 Filed Nov 19, 2024 20:00 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | SaleClass A Common Stock | 20,359 | $69.78 | $1,420,663.24 |
DisclosureSEC source: 0000950170-24-128961 · ownership.xml · nonDerivative · entry 1 ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · CIK 0001883139 · 10% owner MOUNT SINAI HEALTH SYSTEM, INC. · CIK 0001883135 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,846,474 F1 · balance_after: Reflects securities directly held by Icahn School of Medicine at Mount Sinai. The sole member of Icahn School of Medicine at Mount Sinai is Mount Sinai Health System, Inc. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 17:00 UTC | Renalytix plc RNLX · Entity 7446 | OtherOrdinary Shares | 13,366,750 | $0.12 | $1,550,543.00 |
DisclosureSEC source: 0000950170-24-121609 · ownership.xml · nonDerivative · entry 1 ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · CIK 0001883139 · 10% owner MOUNT SINAI HEALTH SYSTEM, INC. · CIK 0001883135 · 10% owner MOUNT SINAI HOSPITAL · CIK 0001899689 · 10% owner MOUNT SINAI HOSPITALS GROUP, INC. · CIK 0001885494 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,683,998 F1 · shares: On November 1, 2024, Icahn School of Medicine at Mount Sinai ("ISMMS") acquired 13,366,750 Ordinary Shares of the Issuer in a private placement of the Issuer (the "Private Placement") pursuant to the Subscription Letter dated as of September 30, 2024, after the Issuer's receipt of the requisite shareholder approval. In connection with the Private Placement, the Issuer, in two tranches, issued (a) an aggregate of 92,773,922 Ordinary Shares pursuant to a Placing Agreement with Oberon Investments Limited, (b) an aggregate of 38,387,634 Ordinary Shares (including the Ordinary Shares issued to ISMMS) to certain investors pursuant to Subscription Letters, and (c) an aggregate of 36,550,543 Ordinary Shares as a result of the restructuring of certain convertible bonds. F2 · price: ISMMS acquired the Ordinary Shares for approximately $1.55 million, which is equivalent to a price of 9 pence per Ordinary Share (or approximately $0.116 per share based on a conversion rate of 1 GBP to $1.2920 on November 1, 2024). F3 · ownership.direct: The securities reported herein are held directly by ISMMS. F4 · ownership.direct: As the sole member of The Mount Sinai Hospital ("MSH"), Mount Sinai Hospitals Group, Inc. ("MSHG") may be deemed to beneficially own the securities held by MSH. As the sole member of MSHG, Mount Sinai Health System, Inc. ("MSHS") may be deemed to beneficially own the securities beneficially owned by MSHG. As the sole member of ISMMS, MSHS may be deemed to beneficially own the securities held by ISMMS. Each of the reporting persons disclaims beneficial ownership of all such securities reported herein, except to the extent of its pecuniary interest, if any. Read SEC document |
| October 31, 2024 Filed Nov 4, 2024 17:01 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | SaleClass A Common Stock | 865,800 | $75.00 | $64,935,000.00 |
DisclosureSEC source: 0000950170-24-120867 · ownership.xml · nonDerivative · entry 1 ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · CIK 0001883139 · 10% owner MOUNT SINAI HEALTH SYSTEM, INC. · CIK 0001883135 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,866,833 F1 · balance_after: Reflects securities directly held by Icahn School of Medicine at Mount Sinai. The sole member of Icahn School of Medicine at Mount Sinai is Mount Sinai Health System, Inc. All share amounts presented in this report reflect the 33:1 reverse stock split of the Issuer's Class A common stock effective May 4, 2023. Read SEC document |
| April 24, 2024 Filed Apr 26, 2024 16:01 UTC | Renalytix plc RNLX · Entity 7446 | OtherOrdinary Shares | 9,360,374 | $0.25 | $2,340,093.50 |
DisclosureSEC source: 0000950172-24-000236 · form4.xml · nonDerivative · entry 1 ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · CIK 0001883139 · 10% owner MOUNT SINAI HOSPITAL · CIK 0001899689 · 10% owner MOUNT SINAI HEALTH SYSTEM, INC. · CIK 0001883135 · 10% owner MOUNT SINAI HOSPITALS GROUP, INC. · CIK 0001885494 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,317,248 F1 · shares: On April 24, 2024, Icahn School of Medicine at Mount Sinai ("ISMMS") acquired 9,360,374 Ordinary Shares of the Issuer in the second tranche (the "Second Tranche") of a private placement of the Issuer (the "Private Placement") pursuant to the Placing Agreement dated March 12, 2024 with Stifel Nicolaus Europe Limited ("Stifel"). The Issuer issued 19,986,031 Ordinary Shares in the first tranche of the Private Placement, which was closed on March 14, 2024, and 26,815,841 Ordinary Shares in the Second Tranche, which was closed on April 24, 2024 after the receipt of the requisite shareholder approval. F2 · price: ISMMS purchased the Ordinary Shares for approximately $2.3 million, which is equivalent to a price of 20 pence per Ordinary Share (or approximately $0.25 per share based on a conversion rate of 1 GBP to $1.2498 on April 23, 2024). F3 · ownership.direct: The securities reported herein are held directly by ISMMS. F4 · ownership.direct: As the sole member of The Mount Sinai Hospital ("MSH"), Mount Sinai Hospitals Group, Inc. ("MSHG") may be deemed to beneficially own the securities held by MSH. As the sole member of MSHG, Mount Sinai Health System, Inc. ("MSHS") may be deemed to beneficially own the securities beneficially owned by MSHG. As the sole member of ISMMS, MSHS may be deemed to beneficially own the securities held by ISMMS. Each of the reporting persons disclaims beneficial ownership of all such securities reported herein, except to the extent of its pecuniary interest, if any. Read SEC document |
| January 31, 2023 Filed Feb 2, 2023 18:35 UTC | GeneDx Holdings Corp. WGS · Entity 1634 | PurchaseClass A Common Stock | 28,571,428 | $0.35 | $9,999,999.80 |
DisclosureSEC source: 0001209191-23-006400 · doc4.xml · nonDerivative · entry 1 ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · CIK 0001883139 · 10% owner MOUNT SINAI HEALTH SYSTEM, INC. · CIK 0001883135 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,176,901 F1 · balance_after: Reflects securities directly held by Icahn School of Medicine at Mount Sinai. The sole member of Icahn School of Medicine at Mount Sinai is Mount Sinai Health System, Inc. Read SEC document |
| April 29, 2022 Filed May 5, 2022 19:27 UTC | GeneDx Holdings Corp. SMFR · Entity 1634 | PurchaseClass A Common Stock | 6,250,000 | $4.00 | $25,000,000.00 |
DisclosureSEC source: 0001209191-22-027435 · doc4.xml · nonDerivative · entry 1 ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · CIK 0001883139 · 10% owner MOUNT SINAI HEALTH SYSTEM, INC. · CIK 0001883135 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,605,473 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.